Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy

Background: Treatment of breast cancer (BC) includes locoregional and systemic therapies depending on tumor and patient’s characteristics. Inositol hexaphosphate (IP6) is known as a strong antioxidant agent, able to improve local (i.e., breast region) side effects, functional status and quality-of-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Amabile, Maria Ida, De Luca, Alessandro, Tripodi, Domenico, D’Alberti, Elena, Melcarne, Rossella, Imbimbo, Giovanni, Picconi, Orietta, D’Andrea, Vito, Vergine, Massimo, Sorrenti, Salvatore, Molfino, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400775/
https://www.ncbi.nlm.nih.gov/pubmed/34442400
http://dx.doi.org/10.3390/jpm11080756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400775/
https://www.ncbi.nlm.nih.gov/pubmed/34442400
http://dx.doi.org/10.3390/jpm11080756

Ejemplares similares